Testing a cholesterol medication added to liver disease treatment

This trial is testing whether atorvastatin, a common cholesterol medication, can help people with advanced liver cirrhosis when added to their current treatment. Right now, doctors are unsure whether this medication is safe and helpful for liver patients, even though early research suggests it might reduce liver disease worsening. The study will follow 50 people for one year to see if the combination treatment works better than current care alone.

Advanced liver cirrhosis causes serious complications like internal bleeding, belly swelling, and confusion, and there aren't many treatment options available. While the medication being tested has been used safely in other patients, doctors have historically avoided it in liver disease out of caution. This trial will help determine whether adding this treatment to standard care could slow disease progression and prevent life-threatening complications.